ELV · 10-Q · 2026Q2 · Full report
Medical Cost Trends
Elevance Health, Inc. · 2026-07-15 · Importance 50 · Surprise 24 · Contradicted
Elevance cites elevated medical cost trends driven by utilization and unit cost increases across provider types, with specific pressure from specialty pharmaceuticals and new indications for existing drugs. The company points to Medicaid population acuity, utilization growth and membership shifts (post-redetermination) as key contributors to higher morbidity and cost. Management highlights numerous drivers — provider contracting inflation, labor costs and health fraud/waste — that can cause variance from estimates and complicate pricing. These cost trends are being managed through care/condition management, specialty pharmacy management, utilization management and payment integrity programs.
Key facts
- Our benefit expense ratio was 89.7% for the three months ended June 30, 2026 and 88.9% for the three months ended June 30, 2025, an increase of 80 basis points. source
- Benefit expense for the three months ended June 30, 2026 was $37,024 compared to $36,706 for the three months ended June 30, 2025, an increase of $318 (0.9%). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| margin | negative | realized | -0.8% | Our benefit expense ratio was 89.7% for the three months ended June 30, 2026 and 88.9% for the three months ended June 30, 2025, an… |
| operating_income | negative | realized | -0.6% | Benefit expense for the three months ended June 30, 2026 was $37,024 compared to $36,706 for the three months ended June 30, 2025, an… |
| net_income | negative | realized | -0.6% | Benefit expense for the three months ended June 30, 2026 was $37,024 compared to $36,706 for the three months ended June 30, 2025, an… |